No significant changes of uric acid or notable adverse events were observed in any of the subjects. In summary, this study showed that oral administration of nattokinase could be considered as a CVD nutraceutical by decreasing plasma levels of fibrinogen, factor VII, and factor VIII.

Nattokinase

Health conditions analyzed in this study

Functions related to this study

Heart health

1 supplement Slightly Positive Nattokinase

---

Body systems related to this study

Cardiovascular System

1 supplement Nattokinase